Matthew Perrone

Read the latest stories and analysis from Matthew Perrone.

FDA weighs over-the-counter approval of Singulair

FDA weighs over-the-counter approval of Singulair

Matthew Perrone · April 30, 2014 2:44 pm

FDA wants stricter safety rules for pelvic mesh

FDA wants stricter safety rules for pelvic mesh

Matthew Perrone · April 29, 2014 10:11 pm

FDA reviews psychiatric side effects of Chantix

FDA reviews psychiatric side effects of Chantix

Matthew Perrone · April 25, 2014 9:35 pm

FDA OKs first-ever DNA alternative to Pap smear

FDA OKs first-ever DNA alternative to Pap smear

Matthew Perrone · April 24, 2014 10:06 pm

FDA warns of cancer risk with fibroid procedure

FDA warns of cancer risk with fibroid procedure

Matthew Perrone · April 17, 2014 9:28 pm

DNA alternative to Pap smear sparks medical debate

DNA alternative to Pap smear sparks medical debate

Matthew Perrone · April 15, 2014 7:23 pm

Under fire, Zohydro maker touts drug safety board

Under fire, Zohydro maker touts drug safety board

Matthew Perrone · March 26, 2014 1:29 pm

Marijuana study in veterans wins federal backing

Marijuana study in veterans wins federal backing

Matthew Perrone · March 17, 2014 2:03 pm

FDA chief defends Zohydro as criticism intensifies

FDA chief defends Zohydro as criticism intensifies

Matthew Perrone · March 13, 2014 6:30 pm

OxyContin maker to offer abuse-resistant Zohydro

OxyContin maker to offer abuse-resistant Zohydro

Matthew Perrone · March 12, 2014 4:13 pm

Medical groups question price of new hep C drug

Medical groups question price of new hep C drug

Matthew Perrone · March 11, 2014 6:17 pm

Endo gets US approval for long-acting testosterone

Endo gets US approval for long-acting testosterone

Matthew Perrone · March 6, 2014 5:14 pm